ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System

Contributed by: GlobeNewswire

Tags

Clinical study

More Like This

ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury

Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy

ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights

ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025

ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025

ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights

ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States

ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury